Economic evaluations of anticoagulants for the prophylaxis of venous thromboembolism following major trauma

References

• Selby R, Geerts WH. Venous thromboembolism prophylaxis after trauma: dollars and sense. Crit. Care Med.29, 1839–1840 (2001).
   PubMed Web of Science ®Google Scholar
• Anderson DR, O’Brien BJ, Levine MN et al. Efficacy and cost of low-molecular weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty. Ann. Intern. Med.119, 1105–1112 (1993).
   PubMed Web of Science ®Google Scholar
• Lensing AW, Hirsch J, Buller HR. Diagnosis of venous thromboembosis. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Coleman RW, Hirsch J, Marder VJ, Salsman EW (Eds). JB Lippincott, Philadelphia, PA, USA 1297–1321 (1994).
   Google Scholar
• Geerts WH, Pineo GF, Heit JA et al. Prevention of venous thromboembolism: The seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest126, S338–S400 (2004).
   PubMedGoogle Scholar
• Geerts WH, Heit JA, Clagett GP et al. Prevention of venous thromboembolism. Chest119, S132–S175 (2001).
   PubMed Web of Science ®Google Scholar
• Pasquale M, Fabian TC and the EAST Ad Hoc Committee on Practice Management Guideline Development: Practice management guidelines for trauma from the Eastern Association for the Surgery of Trauma. J. Trauma44, 941–957 (1998).
   PubMedGoogle Scholar
• Bick RL. Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism. Drugs60, 575–595 (2000).
   PubMed Web of Science ®Google Scholar
• Sprague S, Cook DJ, Anderson D, O’Brien BJ. A systematic review of economic analyses of low-molecular-weight heparin for the treatment of venous thromboembolism. Thromb. Res.112, 193–201 (2002).
   Web of Science ®Google Scholar
• Drummond MF, O’Brien BJ, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes (2nd Edition). Oxford University Press, Oxford, UK (1997).
   Google Scholar
• Geerts WH, Jay RM, Code KI. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N. Engl. J. Med.335, 701–707 (1996).
   PubMed Web of Science ®Google Scholar
• Bick RL. Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism. Drugs60, 575–595 (2000).
   PubMed Web of Science ®Google Scholar
• Meissner MH, Chandler WL, Elliott JS. Venous thromboembolism in trauma: a manifestation of systemic hypercoagulability? J. Trauma54, 224–231 (2003).
   PubMed Web of Science ®Google Scholar
• Geerts WH, Code KI, Jay RM et al. A prospective study of venous thromboembolism after major trauma. N. Engl. J. Med.331, 1601–1606 (1994).
   PubMed Web of Science ®Google Scholar
• O’Malley KF, Ross SE. Pulmonary embolism in major trauma patients. J. Trauma37, 205–208 (1994).
   PubMedGoogle Scholar
• Shackelfor SK, Moser K. Deep vein thrombosis and pulmonary embolism in trauma patients. J. Intensive Care Med.2, 87–98 (1988).
   Google Scholar
• Cipolle MD, Wojcik R, Seislove E et al. The role of surveillance duplex scanning in preventing venous thrombosis embolism in trauma patients. J. Trauma52, 453–462 (2002).
   PubMedGoogle Scholar
• Velmahos GC, Kern J, Chan LS et al. Prevention of venous thromboembolism after injury: an evidence-based report: Part II. Analysis of risk factor and evaluation of the role of vena caval filters. J. Trauma49, 140–144 (2000).
   PubMedGoogle Scholar
• Rogers FB, Cipolle MD, Velmahos G et al. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST Practice Management Guideline work group. J. Trauma53, 143–164 (1990).
   Google Scholar
• Fisher CG, Blachut PA, Salvain AJ et al. Effectiveness of leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients: a prospective, randomized study of compression alone versus no prophylaxis. J. Orthop. Trauma9, 1–7 (1995).
   PubMed Web of Science ®Google Scholar
• Haentjens P. Thromboembolic prophylaxis in orthopaedic trauma patients: a comparison between fixed dose and an individually adjusted dose of low molecular weight heparin. Injury27, 385–390 (1996).
   PubMed Web of Science ®Google Scholar
• Cohn SM, Moller BA, Feinstein AJ et al. Prospective trial of low-molecular-weight heparin versus unfractionated heparin in moderately injured patients. Vasc. Surg.33, 219–223 (1999).
   Google Scholar
• Elliott CG, Dudney TM, Egger M et al. Calf-thigh sequential pneumatic compression compared with plantar venous pneumatic compression to prevent deep-vein thrombosis after non-lower extremity trauma. J. Trauma47, 25–32 (1999).
   PubMedGoogle Scholar
• Clagett GP, Anderson FA, Heit J, Levine MN, Wheeler HB. Prevention of venous thromboembolism. Chest108(Suppl.), S313–S334 (1995).
   Google Scholar
• Shackford SR, Davis JW, Hollingsworth-Fridlund P et al. Venous Thromboembolism in patients with major trauma. Am. J. Surg.159, 365–369 (1990).
   PubMed Web of Science ®Google Scholar
• Knudson MM, Lewis FR, Clinton A et al. Prevention of venous thromboembolism in trauma patients. J. Trauma37, 480–487 (1994).
   PubMedGoogle Scholar
• Napolitano LM, Garlapati VS, Heard SO et al. Asymptomatic deep venous thrombosis in the trauma patients: is an aggressive screening protocol justified? J. Trauma39, 651–659 (1995).
   PubMedGoogle Scholar
• McMurty AL, Owings JT, Anderson JT et al. Increased use of prophylactic vena cava filters in trauma patients failed to decrease overall incidence of pulmonary embolism. J. Am. Coll. Surgeons189, 314–320 (1999).
   PubMed Web of Science ®Google Scholar
• Devlin JW, Petitta A, Shepard AD, Obeid FN. Cost–effectiveness of enoxaparin versus low-dose heparin for prophylaxis against venous thrombosis after major trauma. Pharmacotherapy18, 1335–1342 (1998).
   PubMed Web of Science ®Google Scholar
• Lynd LD, O’Brien BJ. Cost–effectiveness of the implantable cardioverter defibrillator: a review of current evidence. J. Cardiovasc. Electrophysiol.14, S99–S103 (2003).
   PubMed Web of Science ®Google Scholar
• Lynd LD, Goeree R, O’Brien BJ. Antiviral agents for influenza: a comparison of cost–effectiveness data. Pharmacoeconomics23(11), 1083–1106 (2005).
   PubMed Web of Science ®Google Scholar
• Shorr AF, Ramage DO. Enoxaparin for thromboprophylaxis after major trauma: potential cost implications. Crit. Care Med.29, 1659–1665 (2001).
   PubMed Web of Science ®Google Scholar
• Lynd LD, Goeree R, Crowther M, O’Brien BJ. A probabilistic cost–effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep vein thrombosis following major trauma. Can. J. Clin. Pharmacol. (2007) (In press).
   Google Scholar
• Cook D, McMullin J, Hodder R et al. Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey. Crit. Care5(6), 336–342 (2001).
   PubMed Web of Science ®Google Scholar
• Etchells E, Mcleod RS, Geerts GE et al. Economic analysis of low-dose heparin versus the low-molecular-weight heparin enoxaparin for prevention of venous thromboembolism. Arch. Intern. Med.159, 1221–1228 (1999).
   PubMedGoogle Scholar
• Hull RD, Pineo GE, Raskob GE et al. The economic impact of treating deep vein thrombosis with low-molecular heparin: outcome of therapy and health economy aspects. Haemostasis28(Suppl. 3), 8–16 (1998).
   PubMedGoogle Scholar
• Gallus AS. Venous thromboembolism: incidence and clinical risk factors. In: Venous Thromboembolism: prevention and treatment. Madden JL, Hum M (Eds). Appleton-Century-Crofts, NY, USA 1–32 (1976).
   Google Scholar
• Kakkar VV, Flane C, Howe CT. et al. Natural history of postoperative deep vein thrombosis. Lancet2, 230–233 (1969).
   PubMed Web of Science ®Google Scholar
• Lensing AWA, Pradon P. Distribution of venous thrombi in symptomatic patients. Thromb. Haemostasis65, 1730 (1991).
   Google Scholar
• Oster G, Turden RL, Colditz GA. A cost–effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopaedic surgery. JAMA257, 203–208 (1987).
   PubMed Web of Science ®Google Scholar
• Anderson DR, O’Brien BJ, Levine MN et al. Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty. Ann. Intern. Med.119, 1105–1112 (1993).
   PubMed Web of Science ®Google Scholar
• O’Brien BJ, Anderson DR, Goeree R. Cost–effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement. Can. Med. Assoc. J.150, 1083–1090 (1994).
   PubMed Web of Science ®Google Scholar
• van Hout BA, Ai MJ, Gordon GS et al. Costs, effects and C/E ratios alongside a clinical trial. Health Econ.3, 309–319 (1994).
   PubMed Web of Science ®Google Scholar
• Levine M, Gent M, Hirsh J et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N. Engl. J. Med.334(11), 677–681 (1996).
   PubMed Web of Science ®Google Scholar
• Hirsh J, Lee AY. How we diagnose and treat deep vein thrombosis. Blood150, 1083–1090 (2002).
   Google Scholar
• Stinnett AA, Mullahy J. The negative side of cost–effectiveness analysis. JAMA277(24), 1931–1932 (1997).
   PubMed Web of Science ®Google Scholar
• Briggs A, O’Brien BA, Blackhouse G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost–effectiveness studies. Annu. Rev. Public Health23, 377–401 (2002).
   PubMed Web of Science ®Google Scholar
• Black WC. The CE plane: a graphic representation of cost–effectiveness. Med. Decis. Making10, 212–214 (1990).
   PubMed Web of Science ®Google Scholar
• Briggs AH, O’Brien BJ. The death of cost-minimization analysis? Health Econ.10, 179–174 (2001).
   PubMed Web of Science ®Google Scholar
• Nathans AB, McMurray MK, Cuschieri J et al. The practice of venous thromboembolism prophylaxis in the major trauma patient. J. Trauma62, 557–563. (2007).
   PubMedGoogle Scholar
• Velmahos GC. Post-traumatic thromboprophylaxis revisited: an argument against current methods of DVT and PE prophylaxis after injury. World J. Surg.30, 483–487 (2006).
   PubMed Web of Science ®Google Scholar
• Stannard JP, Lopez-Ben RR, Volgas DA et al. Prophylaxis against deep-vein thrombosis following trauma: a prospective, randomized comparison of mechanical and pharmacologic prophylaxis. J. Bone Joint Surg.88(2), 261–266 (2006).
   PubMedGoogle Scholar